https://www.taxtmi.com/caselaws?id=88332 Lanolin anhydrous I.P. was considered for tariff classification under Heading 15.07 and for exemption as a pharmacopoeial bulk drug under the relevant notifications. The record indicated that the product was distinct from degras, was described in the Pharmacopoeia as a pharmaceutical aid, conformed to I.P. standards, and was used in medicinal preparations, which supported examination of exemption criteria tied to pharmacopoeial standards and medicinal use. Because the proper tariff entry had not been satisfactorily determined by a speaking order, the matter was remanded for reconsideration of classification and the consequential exemption claim on the chemical and pharmacopoeial evidence. en-us Fri, 13 Feb 1998 00:00:00 +0530 Fri, 16 Sep 2011 18:50:57 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=88332 Lanolin anhydrous I.P. was considered for tariff classification under Heading 15.07 and for exemption as a pharmacopoeial bulk drug under the relevant notifications. The record indicated that the product was distinct from degras, was described in the Pharmacopoeia as a pharmaceutical aid, conformed to I.P. standards, and was used in medicinal preparations, which supported examination of exemption criteria tied to pharmacopoeial standards and medicinal use. Because the proper tariff entry had not been satisfactorily determined by a speaking order, the matter was remanded for reconsideration of classification and the consequential exemption claim on the chemical and pharmacopoeial evidence. Case-Laws Central Excise Fri, 13 Feb 1998 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=88332